Privia Health Reports Strong 2025 Financials with Double-Digit Growth Across Key Metrics and Strategic Acquisitions
PRVA sits 33% above its 52-week low of $18.77 on elevated volume (3.5× avg).
Summary
Privia Health Group reported strong financial results for 2025, with significant year-over-year growth in revenue, operating income, and net income, supported by strategic acquisitions and expansion in its provider network.
Key Events · Earnings and Guidance · PRVA
-
Strong Financial Performance in 2025
Revenue increased by 22.3% to $2.12 billion, operating income surged by 101.6% to $34.2 million, and net income attributable to Privia Health Group, Inc. grew by 59.3% to $22.9 million for the year ended December 31, 2025.
-
Significant Growth in Key Operational Metrics
The number of implemented providers grew by 12.3% to 5,380, and attributed lives increased by 22.7% to 1.54 million, indicating successful expansion of the company's healthcare delivery network.
-
Strategic Acquisitions Drive Expansion
Privia Health invested $180.37 million in business acquisitions during 2025, including a majority ownership in PMG AZ and an ACO business from Evolent Health, Inc., contributing $51.9 million in revenue post-acquisition.
-
Continued Shift to Value-Based Care
Value-Based Care (VBC) revenue constituted 29.0% of total revenue in 2025, with shared savings revenue increasing by 31.0%, reflecting the company's success in VBC arrangements.
Analysis · PRVA · Industrial Applications And Services
Privia Health Group, Inc. filed its annual 10-K report for the year ended December 31, 2025, confirming robust financial performance and strategic expansion. The company achieved substantial growth in revenue, operating income, and net income, driven by an increase in implemented providers and attributed lives. Significant investments in acquisitions during 2025 underscore an aggressive growth strategy. This detailed annual report follows a preliminary 8-K announcement, providing comprehensive audited financial results and operational insights.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PRVA was trading at $24.88 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $18.77 to $26.51. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.